亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

The Impact of Age and Gender on Outcomes of Patients With Advanced Renal Cell Carcinoma Treated With Targeted Therapy

医学 肾细胞癌 不利影响 内科学 比例危险模型 肿瘤科 癌症 年轻人 临床试验
作者
Justine Panian,Xun Lin,Ronit Simantov,Ithaar Derweesh,Toni K. Choueiri,Rana R. McKay
出处
期刊:Clinical Genitourinary Cancer [Elsevier BV]
卷期号:18 (5): e598-e609 被引量:12
标识
DOI:10.1016/j.clgc.2020.03.010
摘要

A growing body of evidence suggests that age and gender play a role in cancer outcomes. The objective of this study was to investigate the effect of age and gender on survival of patients with metastatic renal cell carcinoma (RCC).We conducted a pooled analysis of patients with metastatic RCC treated on phase II and III clinical trials. Patients were stratified by age (young [<50 years], intermediate [50-70 years], versus elderly [>70 years]) and gender. Statistical analyses were performed using Cox regression adjusted for several risk factors and the Kaplan-Meier method.We identified 4736 patients with metastatic RCC. Overall, there was no difference in overall survival (OS) when stratified by age (21.0 vs. 17.3 months for elderly vs. intermediate age groups, P = .382; 20.0 vs. 17.3 months for young vs. intermediate age groups, P = .155) or gender (19.8 vs. 19.0 for male vs. female, P = .510). Progression-free survival (PFS) was shorter in younger individuals compared with the intermediate age patients (6.0 vs. 7.1 months, P < .001), but similar across gender groups. Although all grade adverse events were more common in elderly patients (fatigue, diarrhea, decreased appetite, and weight), serious adverse events were similar between groups.Although OS was similar between age groups, younger individuals had a shorter PFS. Gender was not an independent determinant of survival. Elderly patients experienced more adverse events than their younger counterparts. These findings are important to guide clinicians when counseling patients about expectations and toxicity associated with therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
BaooooooMao完成签到,获得积分10
15秒前
愉快的犀牛完成签到 ,获得积分10
17秒前
Sunny完成签到,获得积分10
43秒前
yujie完成签到 ,获得积分10
53秒前
赘婿应助科研通管家采纳,获得10
1分钟前
1分钟前
西柚柠檬完成签到 ,获得积分10
1分钟前
心系天下完成签到 ,获得积分10
1分钟前
Alex-Song完成签到 ,获得积分0
1分钟前
不秃燃的小老弟完成签到 ,获得积分10
2分钟前
3分钟前
Owen应助科研通管家采纳,获得10
3分钟前
年年有余完成签到,获得积分10
3分钟前
胖小羊完成签到 ,获得积分10
4分钟前
5分钟前
领导范儿应助科研通管家采纳,获得10
5分钟前
5分钟前
juan完成签到 ,获得积分10
6分钟前
学术小垃圾完成签到,获得积分10
6分钟前
叁月二完成签到 ,获得积分10
6分钟前
6分钟前
科研通AI2S应助科研通管家采纳,获得10
7分钟前
大模型应助科研通管家采纳,获得10
7分钟前
xingsixs完成签到 ,获得积分10
7分钟前
AprilLeung完成签到 ,获得积分10
8分钟前
9分钟前
深情安青应助科研通管家采纳,获得10
9分钟前
迷茫的一代完成签到,获得积分10
10分钟前
魔笛的云宝完成签到 ,获得积分10
10分钟前
www完成签到,获得积分10
10分钟前
11分钟前
NexusExplorer应助科研通管家采纳,获得10
11分钟前
Akitten发布了新的文献求助10
12分钟前
啥时候吃火锅完成签到 ,获得积分0
12分钟前
上官若男应助科研通管家采纳,获得30
13分钟前
斯文败类应助科研通管家采纳,获得10
13分钟前
李爱国应助科研通管家采纳,获得10
13分钟前
科研通AI2S应助科研通管家采纳,获得10
13分钟前
赘婿应助科研通管家采纳,获得10
13分钟前
田様应助精明晓刚采纳,获得10
13分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990423
求助须知:如何正确求助?哪些是违规求助? 3532158
关于积分的说明 11256513
捐赠科研通 3271046
什么是DOI,文献DOI怎么找? 1805207
邀请新用户注册赠送积分活动 882302
科研通“疑难数据库(出版商)”最低求助积分说明 809234